Full Text View
Tabular View
No Study Results Posted
Related Studies
Long Term Study of Extina in Patients With Seborrheic Dermatitis
This study is ongoing, but not recruiting participants.
Study NCT00703846   Information provided by Stiefel, a GSK Company
First Received: June 20, 2008   Last Updated: June 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Seborrheic Dermatitis
Additional conditions recognized in this trial
Dermatitis
Dermatitis, Seborrheic
More general conditions related to this trial
Sebaceous Gland Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Papulosquamous
Interventions listed in this trial
Extina (ketoconazole) foam, 2%
Additional drug interventions recognized in this trial
Ketoconazole
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Stiefel, a GSK Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services